Public COA audit

Tirzepatide

Audited July 29, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
72
Confidence
83%
Panels
1/7

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
APR-8791503
Identity method
UPLC, Mass Spectrometry (MS)
Sample date
2026-03-20
Issue date
2026-03-27

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

1 of 7 present · 0 passed · 0 failed · 1 reported · 6 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · result on file · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    MS2 ES+ TIC 2.7427, MS2 ES+ TIC 4.7148

  • Purity

    Not on this COA · core

    Reported purity percentage for the analyte.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Heavy metals

    Not on this COA

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Not on this COA · core

    LAL or chromogenic endotoxin assay.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Sterility

    Not on this COA

    Sterility testing where applicable.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • No quantitative purity stated

    Document shows UPLC and MS data but does not explicitly state a purity percentage or pass/fail criteria for purity assessment

  • Identity testing present

    UPLC chromatograms and mass spectrometry data provided showing molecular ion peaks consistent with Tirzepatide

  • Batch number present

    Lot Number APR-8791503 clearly stated

  • Dates present and reasonable

    Received Date: 03/20/2026, Analysis Conducted: 03/27/2026 - 7 day turnaround is reasonable

  • Lab verification needed

    Horizon Analytical listed with website horizonanalytical.com - independent verification of lab credentials recommended

  • Limited testing scope

    Only identity testing performed. No purity quantification, heavy metals, microbial, endotoxin, sterility, or residual solvent testing shown

  • Professional presentation

    Document has professional layout with clear branding, chromatograms, and mass spec data. Includes PubChem CID reference (156588324)

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.